Leading International Wellness Company Selects Dario as Partner for Musculoskeletal Health Improvement Program
Dec 22, 2022
Dario Move to be deployed in Greece and Cyprus to help improve the musculoskeletal health of the general populations
New York, Dec. 22, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today a new partnership with ECES, a leading international wellness company, to deploy Dario Move throughout Greece and Cyprus as part of a planned government sponsored initiative. The program will launch in early 2023 with a mandate to screen a minimum of 50,000 citizens in support of improving musculoskeletal health of the Greek and Cyprus populations.
As a recognized provider of wellness services with deep expertise in improving human performance, ECES is partnering with the public and private entities of Greece and Cyprus to support prevention and enhancement of musculoskeletal health needs in the general population. The program will perform musculoskeletal and biomechanical assessments through providers in both countries along with monitoring and supporting the wellness of the individuals.
Dario's solution, Dario Move, combines Computer Vision (CV) technology and Artificial Intelligence (AI) to accurately assess and address each person's musculoskeletal health with highly individualized programs to prevent injuries and improve human function. The CV screenings provide objective and validated scoring based on the user's movement, and digital exercise therapy programs designed by professionals are tailored using Dario's intelligent platform to meet each person's needs.
"Dario's use of smart technologies like CV in support of highly personalized experiences are central to our success in driving better outcomes for our partners. We are excited to launch Dario Move in support of this important initiative to improve the musculoskeletal health of people in Greece and Cyprus and demonstrate the broad value of our solution," said Rick Anderson, President, Dario.
Musculoskeletal health plays a central role in our overall health but is often siloed from general care and well-being. We are partnering with Greece and Cyprus as part of a broader initiative in the Balkans to make prevention and support more broadly accessible by pairing our expertise in human performance alongside Dario's intelligent digital solution to support better musculoskeletal health for thousands of people," said Nick Kounenakis, CEO and founder, ECES.
ECES LTD (ECES-EU.COM) is committed to improving physical development using prevention, wellness and performance optimization methods. ECES successfully implements injury prevention, mental health solutions and wellness programs to people from all walks of life, started with it proven success with Elite athletes, and sport organizations.
ECES applies a holistic approach to development and sustainability, using the latest technology and expertise to provide a roadmap to enhance the physical and mental wellbeing of our clients.
ECES is based in the European Union and operates programs in Greece, Cyprus and the United States.
About DarioHealth Corp.
DarioHealth Corp. (NASDAQ: DRIO) is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition platform. Our platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Our user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Making the right thing to do the easy thing to do.
Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the expected timing of the program launch and the potential benefits that may be realized by users utilizing Dario Move and the Dario platform. Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company's commercial and regulatory plans for Dario™ as described herein) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
SOURCE DarioHealth Corp.